Moore, J. B.; Sadri, G.; Fischer, A. G.; Weirick, T.; Militello, G.; Wysoczynski, M.; Gumpert, A. M.; Braun, T.; Uchida, S.: The A-to-I RNA Editing Enzyme Adar1 Is Essential for Normal Embryonic Cardiac Growth and Development. CIRCULATION RESEARCH 127 (4), pp. 550 - 552 (2020)
Richter, A. M.; Woods, M. L.; Kuester, M. M.; Walesch, S. K.; Braun, T.; Boettger, T.; Dammann, R. H.: RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice. ONCOGENE 39 (15), pp. 3114 - 3127 (2020)
Szibor, M.; Schreckenberg, R.; Gizatullina, Z.; Dufour, E.; Wiesnet, M.; Dhandapani, P. K.; Debska-Vielhaber, G.; Heidler, J.; Wittig, I.; Nyman, T. A.et al.; Gaertner, U.; Hall, A. R.; Pell, V.; Viscomi, C.; Krieg, T.; Murphy, M. P.; Braun, T.; Gellerich, F. N.; Schlueter, K.-D.; Jacobs, H. T.: Respiratory chain signalling is essential for adaptive remodelling following cardiac ischaemia. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 24 (6), pp. 3534 - 3548 (2020)
Christensen, S. T.; Johansson, S. E.; Warfvinge, K.; Braun, T.; Boettger, T.; Edvinsson, L.; Haanes, K. A.: Exploration of Physiological and Pathophysiological Implications of miRNA-143 and miRNA-145 in Cerebral Arteries. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 74 (5), pp. 409 - 419 (2019)
Dhandapani, P. K.; Begines-Moreno, I. M.; Brea-Calvo, G.; Gaertner, U.; Graeber, T.; Javier Sanchez, G.; Morty, R. E.; Schoenig, K.; tenHoeve, J.; Wietelmann, A.et al.; Braun, T.; Jacobs, H. T.; Szibor, M.: Hyperoxia but not AOX expression mitigates pathological cardiac remodeling in a mouse model of inflammatory cardiomyopathy. SCIENTIFIC REPORTS 9, 12741 (2019)
Hassani, S.-N.; Moradi, S.; Taleahmad, S.; Braun, T.; Baharvand, H.: Transition of inner cell mass to embryonic stem cells: mechanisms, facts, and hypotheses. CELLULAR AND MOLECULAR LIFE SCIENCES 76 (5), pp. 873 - 892 (2019)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).